IVM
InterWest Venture Management Portfolio holdings
AUM
$20.6M
This Quarter Return
-25.27%
1 Year Return
+48.5%
3 Year Return
-59.65%
5 Year Return
-75.84%
10 Year Return
–
AUM
$292M
AUM Growth
+$292M
(-24%)
Cap. Flow
+$15.4M
Cap. Flow
% of AUM
5.28%
Top 10 Holdings %
Top 10 Hldgs %
99.99%
Holding
11
New
1
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Venus Concept
VERO
|
$15.4M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TSRO
1
DELISTED
TESARO, Inc.
TSRO
| $168M | 57.29% |
2,021,738
| – | – |
|
2
Glaukos
GKOS
$5.5B
| $26.1M | 8.93% |
1,018,362
| – | – |
|
|
EIGR
3
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $22.3M | 7.63% |
1,599,592
| – | – |
|
4
MacroGenics
MGNX
$112M
| $20.4M | 6.98% |
1,074,316
| – | – |
|
|
HIND
5
Vyome Holdings, Inc. Common Stock
HIND
$243M
| $16.2M | 5.55% |
2,453,338
| – | – |
|
|
6
Venus Concept
VERO
$4.11M
| $15.4M | 5.28% |
+3,355,786
| New | +$15.4M |
|
7
Cidara Therapeutics
CDTX
$1.66B
| $9.23M | 3.15% |
1,356,813
| – | – |
|
|
IVTY
8
DELISTED
Invuity, Inc
IVTY
| $6.7M | 2.29% |
1,080,272
| – | – |
|
|
AGTC
9
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $5.24M | 1.79% |
1,455,904
| – | – |
|
10
KalVista Pharmaceuticals
KALV
$678M
| $3.22M | 1.1% |
329,942
| – | – |
|
11
Xenon Pharmaceuticals
XENE
$2.98B
| $23K | 0.01% |
8,293
| – | – |
|